Kyoichi Okishio
4PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 25, 2025
Efficacy and Safety of Nivolumab Monotherapy in Patients with High PD-1-Positive CD8/Treg Ratio in Advanced NSCLC and Gastric Cancer: A Phase II, Multicenter Study.Kohei Shitara, Motohiro Tamiya, Kyoichi Okishio
|Mar 05, 2025
Preoperative Maximum Standardized Uptake Value Emphasized in Explainable Machine Learning Model for Predicting the Risk of Recurrence in Resected Non-Small Cell Lung Cancer.Takafumi Iguchi, Kensuke Kojima, Daiki Hayashi
|Jan 05, 2024
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort.Makoto Nishio, Shuji Murakami, Hisato Kawakami
|Jul 22, 2020
Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR).Kyoichi Okishio, Ryo Morita, Junichi Shimizu
Pageof 1
Frequent Collaborators
2 joint publications
Motohiro Tamiya
2 joint publications
Hiroki Izumi
1 joint publications
Makoto Nishio
1 joint publications
Shuji Murakami
1 joint publications
Hisato Kawakami
1 joint publications
Haruki Kobayashi
1 joint publications
Daichi Fujimoto
1 joint publications
Shunichi Sugawara
1 joint publications
Toshiyuki Kozuki
1 joint publications
Yuko Oya
